ABT-046
CAS: 1031336-60-3
Ref. 3D-GRB33660
1mg | Discontinued | ||
5mg | Discontinued | ||
10mg | Discontinued | ||
25mg | Discontinued | ||
50mg | Discontinued |
Product Information
ABT-046 is a drug that was designed to be taken orally. The compound is currently in toxicology studies for human use. It has shown high plasma levels and pharmacology, with no signs of toxicity or adverse effects. ABT-046 has been found to have a clean postprandial profile, which means that it does not cause an increase in triglycerides or lipids when ingested with food, and does not interfere with the absorption of other drugs taken at the same time. ABT-046 also has high bioavailability and is optimized for pharmacokinetics.